The tussle between the two drugmakers has spread from the boardroom to the courtroom to the corridors of Washington ...
Oliver Barnes Pfizer and Novo Nordisk duked it out for who will own Metsera — a coveted biotech that’s developing ...
Stocktwits on MSN
‘Somebody Knows Something:’ Viking Therapeutics Stock Pops To Nearly 3-Month High As Retail Traders Intensely Speculate On M&A Scenarios
Traders floated scenarios ranging from a $20 billion buyout to a potential partnership with UnitedHealth, reviving Viking’s ...
Pfizer Inc. (NYSE: PFE) is one of the best undervalued stocks to buy under $50. Pfizer Inc. (NYSE:PFE) received a rating ...
In today’s Pharmaceutical Executive Daily, we report on new data showing Wegovy’s potential to reduce liver injury in patients with MASH, Eli Lilly’s latest strategic collaborations in gene therapy, ...
The company's shares (LLY) climbed 2.3% Tuesday to end at $988.62 a share, after closing at a record high of $966.64 on Monday. The rally has pushed Lilly's market capitalization up to $934.6 billion, ...
10h
We wanted to help end the pandemic. But no one considered the consequences... we're scarred for life
Multiple people across the globe who stepped forward are speaking about what they say is the debilitating aftermath they now ...
Lower prices for 15 drugs, including Ozempic and Wegovy, are expected to be announced by the end of the month. The price ...
Sarah Hall is leaving her role as president of FCB Health New York. The 2025 MM+M Agency 100 honoree confirmed the personnel move in a statement to MM+M on Tuesday afternoon. “Sarah Hall has decided ...
What Happened: According to Reuters, Pfizer Inc (NYSE: PFE) won the bidding war against Novo Nordisk and will purchase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback